Major Arthritis Trial Launched in Scotland


Applied Clinical Trials

Scotland chosen to lead a £26m clinical trial for arthritis sufferers

SCOTLAND, UK, December 16, 2007-A £26m study of medicines to treat the pain of arthritis, which reinforces Scotland’s place as a leader in the delivery of major clinical trials, was launched today.

The SCOT Trial, (Standard Care versus Celecoxib Outcome Trial), will compare different types of treatment for arthritis-a series of conditions which affects around nine million people in the UK.

The trial compares traditional non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and diclofenac, with a newer NSAID called Celecoxib. Both types of NSAID are prescribed for the treatment of arthritis, but doctors want to know how the newer NSAID Celecoxib compares with the older NSAID in patients with arthritis in terms of long-term safety.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.